aabb-logo-sm

Event

Science & Innovation Forum - Assessing FDA Bacterial Guidance Strategies: Perspectives from Canadian Blood Services, the American Red Cross, and OneBlood

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Thursday, September 9, 2021 - On-Demand Available

Presented by Cerus Corporation

CerusWith the October 1 compliance deadline approaching rapidly, US blood collectors are making their final choices among the different options allowed under the FDA bacterial guidance. Some are choosing to pathogen reduce (PR) their platelets, while others are updating their bacterial detection methods. In this webinar, Canadian Blood Services (CBS) and the American Red Cross (ARC) present their experiences with use of the anaerobic culture. Though the culture methodologies discussed by CBS and ARC differ from final FDA guidance methods, these discussions may provide insights when assessing Guidance options as virtually all culture-based detection strategies now require the addition of anaerobic culture. OneBlood will provide their approach to complying with the FDA guidance, including the rationale for pathogen reducing the majority of OneBlood’s platelet inventory; blood safety, availability, and operational aspects will be discussed from both the blood center and transfusion services perspectives.

Registration

This Science & Innovation Forum is complimentary to all, but registration is required. By registering for this AABB-hosted program you consent to have your information shared with the program sponsor, Cerus Corporation. Register here.

  • Faculty

    Moderator: Marion Lanteri, PhD, Director of Scientific Affairs, Cerus

    Speakers:

    Sandra Ramirez-Arcos, BSc, MSc, PhDSandra Ramirez-Arcos, BSc, MSc, PhD
    Senior Scientist
    Canadian Blood Services
    Adjunct Professor
    University of Ottawa

    Pampee P. Young, MD, PhDPampee P. Young, MD, PhD
    Chief Medical Officer, Biomedical Services
    American Red Cross
    Adjunct Professor of Pathology, Microbiology and Immunology
    School of Medicine, Vanderbilt University

    Rita A. Reik, MD, FCAPRita A. Reik, MD, FCAP
    Chief Medical Officer
    OneBlood


    The content of this event was developed independently from the AABB continuing education program. The opinions expressed are those of the faculty. Continuing education credit is not offered.

    Science & Innovation Forums are live and on-demand programs that are presented by companies serving the AABB community and target critical needs in the field that can be addressed by the sponsor’s solutions technology. Registration is complimentary to all.

    Register